Today's Headlines
Individuals with schizophrenia are significantly more likely to live longer if they take their antipsychotic drugs on schedule, avoid extremely high doses, and also regularly see a mental health professional, according to results of a Johns Hopkins study, published in Schizophrenia Bulletin. » Full article |
ADVERTISEMENT
Save on Rx after Brand-Generic Maxed 
Download Savings Calculator
Health care payers attempting to reduce Rx spending may have exhausted their potential to switch members from brand to generic. One solution is to move members from their current brand drugs to less expensive alternative brands with equivalent therapeutic intent Calculate potential savings here. |
|
Prescription-drug treatment regimens for conditions are a normal part of aging are now costing the nation more than many serious and potentially life-threatening disease, according to new research from Express Scripts. » Full article |
|
Patients with nonvalvular atrial fibrillation (NVAF) who also have diabetes experienced similar safety and efficacy with dabigatran etexilate mesylate (Pradaxa) 150 mg or dabigatran 110 mg relative to warfarin, in comparison to patients without diabetes who have NVAF, according to data presented at American Heart Association's Scientific Sessions 2012. » Full article |
CONTINUING EDUCATION
Welcome to the third activity of our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The November activity will cover oral antidiabetes agents and noninsulin injectables for diabetes care.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.
Coming soon - All users will be required to provide their NABP e-Profile ID when logging into the Drug Topics' FREE CPE. This new process requires all pharmacists and pharmacy technicians to provide their NABP e-Profile ID prior to accessing the system. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net This profile will enable you to have one login for all the NABP programs and services you will need throughout your career. |
EDITOR'S PICK
Multiple sclerosis (MS) is a neurologic disorder of chronic inflammation and demyelination of the central nervous system. The disease affects an estimated 400,000 people in the United States, with an onset in young adulthood. The exact cause of MS is unknown; however, both genetic and environmental factors are believed to be involved. Although there is no cure for MS, drug treatments are available with the goal of decreasing relapses and further disability. Nine agents are currently approved for MS, with interferon and glatiramer established as first-line therapies, although their routes of administration may hamper compliance. Several additional agents, including oral products, are now under investigation for the future treatment of MS. » Full article |
|
|
Like
Tweet
